Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
26 September 2019 | Story Ruan Bruwer | Photo Supplied
Kovsies Women Cross-Country Team Marné Mentz, Vicky Oelofse, and Channah du Plessis
Marné Mentz, Ts’epang Sello, and Tyler Beling played a huge role in Kovsies' cross-country champions win.

After coming within a whisker of claiming the title in 2018, the University of the Free State’s (UFS) runners ensured that the University Sports South Africa (USSA) cross-country trophy comes to Bloemfontein in 2019.

Kovsies are the new national student cross-country champions after they (men and women combined) won the USSA Championships in Nelspruit on Saturday, 21 September. Kovsies and the University of Johannesburg (UJ) both finished with three gold medals at the same event in 2018. UJ finished with nine overall medals compared to the eight (three gold, two silver, and three silver) of the UFS, who had to settle for second place. In 2017, the UFS finished third.

The Kovsie women’s team played a huge role in carrying the team to the top of the medal table, winning four golds. They won the 4 km and 10 km women’s team competitions as well as the road relay. The top three places by the runners of a university determined the team winner.

Marné Mentz UFS Cross-Country

Marné Mentz’s gold medal in the four-kilometre race at the
USSA Cross Country Championships helped the Kovsies
win the overall title.

Marné Mentz (first), Vicky Oelofse (fifth), and Channah du Plessis (sixth) dominated the four-kilometre race. In the 10 km, Ts’epang Sello (third), Tyler Beling (sixth), and Lizandré Mulder (seventh) did enough to ensure another gold for the Free State students. Mentz, Sello, and Beling jointly took first place in the road relay.

In the 10-km race for men, Kovsies came fifth, with Victor Makhabesela the best performer (finishing ninth). Pakiso Mthembu, one of the contenders for the medal who won the silver medal at the National Cross Country Championships two weeks before, had to withdraw after 7 km in the race due to an injury.

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept